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Abstract
Background: Three genes have been confirmed as major joint susceptibility genes for endocrine
autoimmune disease:human leukocyte antigen class II, cytotoxic T-lymphocyte antigen 4 and
protein tyrosine phosphatase non-receptor type 22. Recent studies showed that a genetic variation
within the interferon induced helicase domain 1 (IFIH1) locus (rs1990760 polymorphism) is an
additional risk factor in type 1 diabetes and Graves' disease (GD).
Methods: The aim of the present study was to investigate the role of the rs1990760 polymorphism
within the IFIH1 gene in German patients with GD (n = 258), Hashimoto's thyroiditis (HT, n = 106),
Addison's disease (AD, n = 195) and healthy controls (HC, n = 227) as well as in 55 GD families
(165 individuals, German) and 100 HT families (300 individuals, Italian). Furthermore, the
interaction between rs1990760 polymorphism with human leukocyte antigen (HLA) risk haplotype
DQ2(DQA*0501-DQB*0201), the risk haplotypes DQ2/DQ8 (DQA*0301-DQB*0302) and the
status of thyroglobulin antibody (TgAb), thyroid peroxidase antibody (TPOAb) and TSH receptor
antibody (TRAb) in patients and families were analysed.
Results: No significant differences were found between the allele and genotype frequencies for
rs1990760 IFIH1 polymorphism in patients with GD, HT, AD and HC. Also no differences were
observed when stratifying the IFIH1 rs1990760 polymorphism for gender, presence or absence of
thyroid antibodies (GD:TRAb and HT:TPOAb/TgAb) and HLA risk haplotypes (DQ2:for GD and
HT, DQ2/DQ8:for AD). Furthermore the transmission analysis in GD and HT families revealed no
differences in alleles transmission for rs1990760 IFIH1 from parents with or without HLA risk
haplotype DQ2 to the affected offspring. In contrast, by dividing the HT parents according to the
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presence or absence of thyroid Ab titers, mothers and fathers both positive for TPOAb/TgAb
overtransmitted the allele A of IFIH1 rs1990760 to their HT affected offspring (61.8% vs 38.2%;p
= 0.05;corrected p [pc] = 0.1). However, these associations did not remain statistically significant
after correction of the p-values.
Conclusion:  In conclusion, our data suggest, no contribution from IFIH1 rs1990760
polymorphism to the pathogenesis of either Graves' disease, Hashimoto's thyroiditis or Addison's
disease in our study populations. However, in order to exclude a possible influence of the studied
polymorphism in specified subgroups within patients with autoimmune thyroid disease, further
investigations in larger populations are needed.
Background
Autoimmune diseases are characterised by the failure to
maintain self-tolerance, which results from the interaction
between genetic and enviromental factors. The Major His-
tocompatibility Complex, the cytotoxic T lymphocyte
antigen 4 locus and the protein tyrosine phosphatase non-
receptor 22 gene are involved in the pathogenesis of
autoimmune endocrine diseases [1]. Recently, a novel
locus called Interferon-induced helicard (IFIH1),
rs1990760, was identified to be associated with type 1
diabetes (T1D) and Graves' disease [2,3]. IFIH1 gene, also
referred to as melanoma differentiation-associated 5 or
Helicard, is located on the chromosome 2q24 and
encodes an early type I interferon beta responsive gene.
The helicase detects cytoplasmatic viral double strand
RNA (dsRNA), leading to interferon beta production via
activation of interferon regulatory factor-3 (IRF-3) and
nuclear factor kappa-B (NFkB). The inappropriate activa-
tion of these virus-sensitive proteins by self-derived, intra-
cellular nucleic acids might have an effect in
autoimmunity [4]. Therefore and in order to determine
whether IFIH1 rs1990760 polymorphism is involved in
the genetic background of other endocrine autoimmune
disease we compared genotype and allele frequencies in
German patients with Graves' disease (GD), Hashimoto's
thyroiditis (HT), Addison's disease (AD) and healthy con-
trols (HC) and performed transmission disequilibrium
tests (TDT) for that polymorphism in families with GD
(German) and families with HT (Italian). Furthermore,
we analyzed the distribution of IFIH1 rs1990760 poly-
morphism in families and case-controls according to the
presence or absence of the human leukocyte antigen
(HLA) risk haplotype DQ2 (DQA*0501-DQB*0201), risk




Patients of German origin with Graves' disease (n = 258,
207 females and 51 males), Hashimoto's thyroiditis (n =
106, 87 females and 19 males), Addison's disease (n =
195, 138 females and 57 males) and 55 GD families com-
prising both parents and a single affected offspring (165
subjects) were recruited from the endocrine outpatient
clinics at the University Hospitals of Frankfurt am Main,
Freiburg, Wuerzburg, Duesseldorf and Munich, Germany.
Healthy controls (n = 227, 160 females and 67 males)
were volunteer blood donors from the staff personnel or
medical students from the University Hospital Frankfurt
am Main, Germany, without a family story of autoim-
mune diseases. The median age of the patients with GD,
HT, AD and HC was 45 (range 7-80), 37 (range 22-70), 51
(range 19-87) and 42 (range 30-101) years respectively.
The median age of affected offspring from the 55 GD fam-
ilies was 43 (range 26-55) years. Additionally,100 Hashi-
moto's thyroiditis families (300 subjects) were recruited
from the Pediatrics Endocrinology University "La
Sapienza," Rome, Italy. The median age of affected off-
spring was 11 (range 2-21) years.
Graves' disease diagnosis rested on autoimmune hyper-
thyroidism with TSH receptor antibodies and/or ophthal-
mopathy. Hashimoto's thyroiditis was diagnosed by
positive thyroglobulin (Tg) and/or thyroid peroxidase
antibodies, reduced echogenicity on thyroid ultrasound,
and normal or elevated thyrotropin (TSH) levels. Addi-
son's disease was diagnosed by primary adrenocortical
insufficiency without evidence of tuberculosis or adreno-
leucodystronphy. The study protocol was approved by the
ethics committee of the University Hospital Frankfurt am
Main, Germany and the University "La Sapienza," Rome,
Italy. A informed consent was obtained from all partici-
pants.
Genotype analysis
Blood samples were collected in ethylenediamine
tetraacetic acid-anticoagulated tubes from study partici-
pants and genomic DNA was extracted using salting out
procedure [5]. The samples were genotyped for IFIH1
rs1990760 polymorphism by using Taqman assay
C__2780299_30 in a ABI 7300 real-time PCR system
under the conditions recommended by the manufacturer
(Applied Biosystems, Darmstadt, Germany). The HLA
DQA1 and DQB1 typing was performed as described pre-
viously [6]. In order to confirm the accuracy of the meth-
ods, random samples of the IFIH1 rs1990760BMC Medical Genetics 2009, 10:126 http://www.biomedcentral.com/1471-2350/10/126
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polymorphism and HLA were genotyped twice with a con-
cordance of 98%.
Measurement of TPO-, TG- and TRAb antibodies
Thyroglobulin antibody (TgAb) and thyroid peroxidase
antibody (TPOAb) were measured by enzyme-linked
Immunosorbent Assay (Phadia, Freiburg, Germany) and
TSH receptor antibodies (TRAb) were determined by
TRAK Assay kit (Brahms, Berlin, Germany).
Statistical analysis
Patients and controls and their subgroups (see results)
were compared using allele-wise and genotype-wise Chi2
testing by using BiAS software (package 8.21, Epsilon,
Weinheim, Germany). Family analyses were estimated
using Haploview software version 3.2 available from http:/
/www.broad.mit.edu/mpg/haploview to detect preferen-
tial transmission of the IFIH1 rs1990760 alleles to the
affected subjects, whereas the correlation with HLA haplo-
types [risk haplotype: DQ2 (DQA*0501-DQB*0201) for
GD and HT and risk haplotypes DQ2/DQ8 (DQA*0301-
DQB*0302) for AD and non risk haplotypes (neither
DQ2, neither DQ2/DQ8, respectively)] and thyroid anti-
bodies (ThyAbs) was evaluated using Unphased software
version 2.403 available from http://www.mrc-
bsu.cam.ac.uk/personal/frank/software/unphased/. All p
values were corrected (Bonferroni correction) by multipli-
cation with the number of alleles tested (× 2). A corrected
p (pc) < 0.05 was considered significant.
Results
Allele and genotype frequencies for IFIH1 rs1990760 pol-
ymorphism in all subjects did not deviate from Hardy-
Weinberg equilibrium (HWE; p > 0.05).
No significant differences were found between the allele
and genotype frequencies for IFIH1 rs1990760 polymor-
phism in patients with GD, HT, AD and HC (Table 1).
Also no differences were observed when stratifying the
rs1990760 IFIH1 polymorphisms according to gender in
each patient groups. Furthermore, GD and HT patient
groups were divided in HLA risk haplotype (DQ2) and
HLA non risk haplotype (neither DQ2), the AD patients
in HLA risk haplotypes (DQ2/DQ8) and non risk haplo-
types (neither DQ2/DQ8). Additionally, following other
subgroups were analysed a) GD: group TRAb positive
(pos)/group TRAb negative (neg), b) HT: group TPOAb
pos/group TPOAb neg, c) HT: group TgAb pos/group
TgAb neg. Next all measured groups were stratified for
gender. However, the comparison between the patient
subgroups and their corresponding control groups did not
reach the level of significance (data not shown).
The transmission analysis for IFIH1 rs1990760 polymor-
phism in 100 HT families (Italy) revealed no differences.
In order to evalute the effect of ThyAb on the IFIH1
rs1990760 polymorphism, the parents were divided into
four subgroups according to their TPOAb/TgAb titers: 39
families, no ThyAb were detectable in either mothers or
fathers (group 1), 35 families, only mothers had detecta-
ble antibodies (group 2), 9 families, only fathers were
positive for antibodies (group 3), and 17 families, both
parents presented detectable antibodies (group 4). The
analysis showed that mothers and fathers in group 4 over-
transmitted the allele A of rs1990760 IFIH1 to their HT
affected offspring (61.8% vs 38.2%; p = 0.05; corrected p
[pc] = 0.1, Table 2).
However, the associations obtained in the family analyses
did not remain statistically significant after correction of
the p-values. Because TRAb titers of the parents in the GD
families were not available, the transmission analysis was
not performed. Additionally, we compared the transmis-
sion of the IFIH1 rs1990760 polymorphism in parents, in
either mothers and fathers in GD and HT families with the
haplotype DQ2 and without DQ2 by TDT. In Italian HT
families as well as the in German GD families the interac-
tion analysis between IFIH1 rs1990760 polymorphism
Table 1: Genotype and allele frequencies for IFIH1 rs1990760 polymorphism in German patients with Graves'disease (GD), 
Hashimoto's thyroiditis (HT), Addison' s disease (AD) and healthy controls (HC)
HD (n = 227) GD (n = 258) HT (n = 106) AD (n = 195)
n %n %pp c n %pp c n %pp c
Genotype
GG 28 12.3 38 14.7 20 18.9 28 14.4
GA 112 49.3 132 51.2 0.55 1.1 45 42.5 0.23 0.46 99 50.8 0.7 1.4
AA 87 38.3 88 31.1 41 38.7 68 34.9
Allele
G 168 37 208 40.3 0.32 0.64 85 40.1 0.49 0.98 155 39.7 0.45 0.9
A 286 63 308 59.7 127 59.9 235 60.3
pc = p correctedBMC Medical Genetics 2009, 10:126 http://www.biomedcentral.com/1471-2350/10/126
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and HLA DQ2 haplotype revealed no difference in the
transmission (data not shown).
Discussion
The innate immune system detects dsRNA, a replication
product of most viruses, within infected cells by Toll-like
receptor 3 and cytoplasmic RNA helicases such as retinoic
acid inducible gene I and interferon-induced helicase.
IFIH1, a 1025 amino acid cytoplasmic protein, protects
the host from viral infection by triggering a cellular antivi-
ral and apoptotic response. In this process IFIH1 signaling
activates transcription factors, IRFs and NFkB pathways
through its caspase recruitment domain (CARD) that
induce IFN-α/β and interferon-inducible genes [7-9].
IFIH1 transcripts were found to be expressed in lymphoid
and other tissues, suggesting a role in autoimmune dis-
eases. A large scale association study of candidate (non-
synonymous, i.e. amino acid changing) polymorphism
identified IFIH1, rs1990760, as a new locus for T1D [2].
The rs1990760 polymorphism is located in HNF-3b bind-
ing site within exon 15, encodes an alanine to threonine
amino acid change at codon 946 (Ala946Thr), which does
not reside in either the CARD or helicase domain of the
protein. However, this region of the protein is conserved
between mammals and may have other, unknown func-
tions or may influence the active domains through effects
on tertiary structure. Ala946 is the fully conserved amino
acid, suggesting that this is the functional allele. The asso-
ciation between IFIH1 rs1990760 polymorphism and
T1D was not only confirmed by other authors [10-12] but
also reported in other autoimmune diseases [3,13,14].
Studies that reported associations between viral infection
and susceptibility to development T1D as well as autoim-
mune thyroid disease (ATD) [15-17], reinforce the IFIH1
gene as a good functional candidate for these autoim-
mune disorders. On the basis on this finding we investi-
gated the role of IFIH1 rs1990760 polymorphism in ATD
including GD, HT and Addison's disease (all Germans)
and enlarge our analysis in the transmission of this poly-
morphism in families with offspring affected with GD and
HT. Similar to other studies, that investigated IFIH1
rs1990760 polymorphism in diverse autoimmune disease
we could not find a association between IFIH1 rs1990760
polymorphism and our case-control study population
[18,19]. In contrast, Sutherland et al. (2007) tested the
same coding variant for association to ATD (646
cases;446 controls) and autoimmune Addison's disease
(204 cases) from Caucasian United Kingdom (UK) and
found that the A allele increased the odds of Graves' dis-
ease 1.47-fold. Since in our study the distribution of
rs1990760 polymorphism in controls (Germans) was not
different from that in UK controls and the fact that Suth-
erland et al. (2007) analogue to our findings did not
detect an association in AD patients, the smaller number
of patients could be an explanation for the lack of an asso-
ciation between endocrine autoimmune diseases and the
rs1990760 polymorphism observed in the present study.
However, the trend associations obtained in the HT fam-
ily in which mothers and fathers were both positive for
TPOAb/TgAb, overtransmitted the allele A of IFIH1
rs1990760 to their HT affected offspring (61.8% vs
38.2%;p = 0.05; corrected p [pc] = 0.1), did not remain
Table 2: Transmission (T) and non transmission (NT) of IFIH1 rs1990760 polymorphism in 100 Hashimoto's thyroiditis families 
(Italian) according to the presence of thyroid antibodies (TPO and TG)
Polymorphism Allele Frequency T NT p pc
rs1990760 (%) n (%) n (%)
Group A 55.5 110 (49.5) 112 (50.5) 0.84 1.68
100 parents G 44.5 90 (50.6) 88 (49.4)
Group 1 A 53.2 38 (45.8) 45 (54.2) 0.26 0.52
39 mo-, fa- G 46.8 40 (54.8) 33 (45.2)
Group 2 A 57.9 41 (50.6) 40 (49.4) 0.86 1.72
35 mo+, fa- G 42.1 29 (49.2) 30 (50.8)
Group 3 A 66.7 10 (41.7) 14 (59.3) 0.15 0.3
9 mo-, fa+ G 33.3 8 (66.7) 4 (33.3)
Group 4 A 50.0 21 (61.8) 13 (38.2) 0.05*1 0.1
17 mo+, fa+ G 50.0 13 (38.2) 21 (61.8)
mo = mothers; fa = fathers
pc = p corrected
*1OR = odds ratio; (95% CI) = 95% confidence interval.
group 4: allele A OR 2.61 (0.98-6.94) and allele G OR 0.38 (0.14-10.2)
p = 0.05BMC Medical Genetics 2009, 10:126 http://www.biomedcentral.com/1471-2350/10/126
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statistically significant after correction of the p-values.
This may reflect that the selection of the patient collectives
could influence the detection of an association.
Also the rare polymorphisms, rs35667974 and
rs35337543 which reside within the IFIH1 gene were
found to be associated with T1D [20] but their effect can
only be studied in large population samples. Nevertheless
these data point to a possible role of IFIH1 in the patho-
genesis of T1D and marke the investigations of large
cohorts necessary.
The IFIH1 rs1990760 polymorphism is in linkage dise-
quilibrium (LD) with other IFIH1 variants for instance
rs2068330, rs2111485 and rs984971 and could be differ-
ent due to population heterogeneity [12]. Therefore the
different patterns of LD across studies and populations
could be a further explanation for the discrepancy of the
results.
Conclusion
We conclude from the results of the present case-control
and families study that there is no significant role of the
IFIH1 rs1990760 polymorphism in the genetic suscepti-
bility to GD, HT and AD in Germans and HT in Italians.
However in order to exclude a possible influence of the
rs1990760 polymorphism in specified subgroups within
patients with ATD further investigations in larger samples
are required. Also other polymorphisms e.g. rs2068330,
rs2111485, rs984971 within the IFIH1 LD block are rec-
ommended to be investigated in future studies, in order to
obtain more suitable markers to analyse the susceptibility
for the development ATD and AD in Germans.
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